Clinical Trials
Contribute to advancing Metabolic Psychiatry®!
If you are an individual interested in exploring the intersection of metabolic health and psychiatric disorders, on this page, you will find opportunities to participate in or learn about ongoing and upcoming trials aimed at understanding and treating illnesses like ADHD, bipolar disorder, schizophrenia, depression and anxiety, addiction, and eating disorders and obesity utilizing metabolic treatments.
Explore Clinical Trials
-
Shebani Sethi, MD
To initiate a low-carbohydrate, high-fat, ketogenic dietary intervention among a small cohort of outpatients with either schizophrenia or bipolar illness and comorbid overweight/obesity currently taking psychotropic medications.
Stanford-affiliated
-
Debra L Safer, MD, Sarah Adler, PsyD, Shebani Sethi, MD
This study demonstrates the efficacy of “Qsymia” versus placebo in treating bulimia nervosa and binge eating disorder.
Stanford-affiliated
-
Anu Ruusunen, PhD
This randomized, controlled pilot study aims to investigate the feasibility of a Modified Ketogenic Diet intervention protocol in psychotic inpatients, and the potential impact of this intervention on psychotic symptoms, depressive and anxiety symptoms, and functioning in patients with psychotic symptoms / psychotic disorder.
Externally-conducted
-
Lori Calabrese, MD
This open-label pilot study aims to determine whether a two-part sequenced outpatient procedure utilizing a modified ketogenic diet followed by a series of titrated ketamine infusions results in improvement or remission of chronic anorexia nervosa in adults with symptoms of anorexia for at least 3 Years.
-
Judith Ford, Ph.D
This work brings together cardiovascular metabolism and psychiatry to address two problems experienced by people with schizophrenia: (1) neural network instability associated with cognitive deficits, and (2) insulin resistance associated with morbidity and mortality.
-
Prof Harry Campbell, Prof Ian Campbell, Dr Nicole Needham
This study will pilot the introduction of a KD for 8 weeks in patients with Bipolar Disorder. The aim is to find out how easy it is to do this, the main challenges, and how to address these.